Betaine Anhydrous Powder, For Solution
FDA Label NDC 71863-115

23 label sections · Submitted to the FDA by Eton Pharmaceuticals, Inc. · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Eton Pharmaceuticals, Inc. for the product Betaine Anhydrous (NDC 71863-115). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding 1. indications and usage, 2. dosage and administration, 2.1 dosage, 2.2 preparation and administration instructions, 3. dosage forms and strengths, 4. contraindications, 5. warnings and precautions, 6. adverse reactions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.